Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,159
datasets available to search
ShareScore release 0.9.0
Dataset results
1,159 results for “covid-19 vaccine”
Influence of conspiracy theories and distrust of community health volunteers on adherence to COVID-19 guidelines and vaccine uptake in Kenya
<p>This cross-sectional study collected data between 25 May –27 June 2021 n=447. It involved all registered community health volunteers (CHVs) who had participated in the COVID-19 vaccine hesitancy study. This data was collected as part of an Epidemic Ethics/WHO initiative that FCDO/Wellcome Grant 214711/Z/18/Z has supported. WHO’s specific grant number was 2020/1077878-0). The funders had no role in study design, data collection and analysis, decision to publish, or manuscript preparation. No authors received a salary from the funders.</p>
Labeled data and models for COVID-19 vaccine related tweets with stance, location, and topics
<p>The dataset contains Tweet IDs along with the location and tweet timestamp. The tweets are labeled based on motivating/demotivating status, stance towards the COVID-19 vaccine, and topic in the tweet text. To comply with Twitter guidelines, we removed the tweet texts and author information. You can use Hydrator API to hydrate the tweets.</p> <p>The repository also contains the machine-learning models for topic modeling, de/motivation classifier, and stance detection from the tweets.</p>
Open microdata registers from the Brazilian COVID-19 vaccination campaign
<p>This repository provides the Brazilian Ministry of Health’s (MoH) open microdata registers from the national COVID-19 vaccination campaign used in the paper <em>Age reporting for the oldest old in the Brazilian COVID-19 vaccination database: what can we learn from it?</em></p> <p>The dataset was downloaded on 14 March 2022 and was initially available at openDataSus <a href="https://opendatasus.saude.gov.br/dataset/covid-19-vacinacao">Campanha Nacional de Vacinação contra Covid-19</a> under a <a href="http://creativecommons.org/licenses/by/4.0/?ref=chooser-v1">CC BY 4.0</a> license.</p> <p>The reproducible <em><code>R</code></em> code and other datasets for the paper are available on GitHub at <a href="https://github.com/demographyandme/covid-19-datasus-vacina">Age reporting for the oldest old in the Brazilian COVID-19 vaccination database: what can we learn from it?</a> </p>
Data used in the study "mRNA vaccination boosts spike-specific T cell memory and promotes expansion of CD45RAint TEMRA-like CD8+ T cells in COVID-19 recovered individuals"
<p>Data associated with an original research study examining T cell responses to mRNA vaccination in COVID-19 recovered individuals. 10X Cell Ranger outputs, bulk TCR sequencing data, and T cell functional (ICS) data in this study have been deposited. Authors KMB and HR contributed equally to this effort. Address correspondence to EWN.</p>
Classifying COVID-19 vaccine narratives
<p>We release the augmented Twitter dataset of 355 vaccine-related narratives, created for the following paper. The tweets are labelled as one of four classes: <em>Conspiracy (Cons), Moral, Religious, and Ethical Concerns (MRE), Liberties and Freedom (LF), and Animal Vaccines (AnimalVac)</em>.</p> <pre>@article{li2022classifying, title={Classifying COVID-19 vaccine narratives}, author={Li, Yue and Scarton, Carolina and Song, Xingyi and Bontcheva, Kalina}, journal={arXiv preprint arXiv:2207.08522}, year={2022} }</pre> <p>The paper has been accepted by RANLP 2023.</p> <p> </p> <p> </p>
Factors Driving Vaccine Hesitancy rrelated to vaccination of children with Covid-19 vaccine among Albanian parents
<p>A validated questionnaire composed of 33 elements was used for the purpose of this study</p> <p>The subjects of this study were parents of children aged 0-18 years old .</p> <p>Inclusion criteria were:albanian parents who understood and spoke well albanian, parents of children aged 0-18 years old, parents aged 18 years old and over. Exclusion criteria were: parents aged less than 18 years old, albanian parents who didn’t understand well albanian language, parents of children aged more than 18 years old.</p>
Characterization of the anti-spike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies
<p>Research on COVID-19 vaccination in immune-deficient/disordered people (IDP) has primarily focused on cancer and organ transplantation populations. In a prospective cohort of 195 IDP and 35 healthy volunteers, anti-spike IgG was detected in 88% of IDP post-dose 2, increasing to 93% by six months post-dose 3. Despite high seroconversion, median IgG levels for IDP never surpassed 1/3 that of healthy volunteers. IgG binding to Omicron BA.1 was lower than all other variants. Angiotensin-converting enzyme 2 pseudo-neutralization (% inhibition) was only modestly correlated with anti-spike IgG concentration. IgG levels were not significantly altered by participants' use of different mRNA-based vaccines, immunomodulating treatments, and prior SARS-CoV-2 infections. While our data show that three doses of COVID-19 vaccinations induce anti-spike IgG in most IDP, additional doses are needed to achieve the levels of protection in healthy volunteers. Due to the strikingly reduced IgG response to Omicron BA.1, the efficacy of additional vaccinations, including bivalent vaccines, should be studied in this population.</p>
Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older
ClinicalTrials.gov study NCT04762680. IPD Sharing: YES. Countries: 7. Publications: 2.
A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)
ClinicalTrials.gov study NCT05299359. IPD Sharing: YES. Countries: 1. Publications: 2.
Evaluation of Full Versus Fractional Doses of COVID-19 Vaccines Given as a Booster in Adults in Australia - Mongolia, Indonesia, Australia Coronavirus (MIACoV).
ClinicalTrials.gov study NCT05228730. IPD Sharing: YES. Countries: 1. Publications: 1.
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial
ClinicalTrials.gov study NCT06547814. IPD Sharing: YES. Countries: 1. Publications: 5.
Exploring Changes in COVID-19 Vaccination Intentions by Prompting Altruistic Motives Using a Video Intervention
ClinicalTrials.gov study NCT04960228. IPD Sharing: NO. Countries: 1. Publications: 3.
Evaluation of Full Versus Fractional Dose of COVID-19 Vaccine Given as a Booster for the Prevention of COVID-19 in Adults in Mongolia.
ClinicalTrials.gov study NCT05265065. IPD Sharing: YES. Countries: 1. Publications: 3.
A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)
ClinicalTrials.gov study NCT04830800. IPD Sharing: NO. Countries: 1. Publications: 1.
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
ClinicalTrials.gov study NCT04952402. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older
ClinicalTrials.gov study NCT04537208. IPD Sharing: YES. Countries: 1. Publications: 2.
COVID-19 Study to Assess Immunogenicity, Safety, and Tolerability of Moderna mRNA-1273 Vaccine Administered With Casirivimab+Imdevimab in Healthy Adult Volunteers
ClinicalTrials.gov study NCT04852978. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-
ClinicalTrials.gov study NCT04969276. IPD Sharing: YES. Countries: 1. Publications: 1.
Addressing Vaccine Hesitancy and Increasing COVID-19 Vaccine Uptake Among African American Young Adults in the South
ClinicalTrials.gov study NCT05490329. IPD Sharing: YES. Countries: 1. Publications: 3.
Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older
ClinicalTrials.gov study NCT04904549. IPD Sharing: YES. Countries: 11. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.